Astle Christopher bought ZYME
January 5, 2024 · Form 4 insider transaction
Astle Christopher bought 50,000 shares of Zymeworks Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderAstle Christopher
RoleOfficer
CompanyZymeworks Inc. (ZYME)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 5, 2024
Filing dateJanuary 8, 2024
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date.